{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:40:14Z","timestamp":1790278814274,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T00:00:00Z","timestamp":1348099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T00:00:00Z","timestamp":1348099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep00679","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T09:10:39Z","timestamp":1348132239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nitric oxide rescues thalidomide mediated teratogenicity"],"prefix":"10.1038","volume":"2","author":[{"given":"Jamila H.","family":"Siamwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Veeriah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Krishna","family":"Priya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttara","family":"Saran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaraj","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunmugam","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"T","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvro","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,20]]},"reference":[{"key":"BFsrep00679_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/pmj.79.929.127","volume":"79","author":"JN Gordon","year":"2003","unstructured":"Gordon, J. N. & Goggin, P. M. Thalidomide and its derivatives: emerging from the wilderness. Postgrad Med J 79(929), 127\u2013132 (2003).","journal-title":"Postgrad Med J"},{"key":"BFsrep00679_CR2","doi-asserted-by":"crossref","unstructured":"Mc Bride. Thalidomide and congenital abnormalities. Lancet ii, 1358 (1961).","DOI":"10.1016\/S0140-6736(61)90927-8"},{"key":"BFsrep00679_CR3","first-page":"2555","volume":"86","author":"W Lenz","year":"1961","unstructured":"Lenz, W. Fragenaus der Praxis: kindliche Missbildungennach Medikament Einnahmewahrend der Graviditat? Dtsch Med Wochenschr. 86, 2555\u20132556 (1961).","journal-title":"Dtsch Med Wochenschr."},{"key":"BFsrep00679_CR4","first-page":"183","volume":"36","author":"SJ Further","year":"1965","unstructured":"Further, S. J. Observation with thalidomide in lepra reactions. Lepr Rev, 36, 183\u2013187 (1965).","journal-title":"Lepr Rev"},{"key":"BFsrep00679_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"EP Sampaio","year":"1991","unstructured":"Sampaio, E. P. et al. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 173(3), 699\u2013703 (1991).","journal-title":"J Exp Med"},{"key":"BFsrep00679_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2133.2005.06747.x","volume":"153","author":"JJ Wu","year":"2005","unstructured":"Wu, J. J. et al. Thalidomide: dermatological indications, mechanisms of action and side-effects. Br J Dermatol 153(2), 254\u2013273 (2005).","journal-title":"Br J Dermatol"},{"key":"BFsrep00679_CR7","first-page":"39","volume":"194","author":"D Locker","year":"1971","unstructured":"Locker, D. Superstine, E, Sulman, F.G. The mechanism of the push and pull principle VIII: endocrine effects of thalidomide and its analogues. Arch. Int. Pharmacodyn. Ther, 194, 39\u201355 (1971).","journal-title":"Arch. Int. Pharmacodyn. Ther"},{"key":"BFsrep00679_CR8","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D'Amato","year":"1994","unstructured":"D'Amato, R. J., Loughnan, M. S., Flynn, E. & Folkman, J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 91(9), 4082\u20134085 (1994).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep00679_CR9","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.0901505106","volume":"106","author":"C Therapontos","year":"2009","unstructured":"Therapontos, C. et al. Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci U S A 106(21), 8573\u20138579 (2009).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep00679_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1096\/fj.06-7603com","volume":"21","author":"J Knobloch","year":"2007","unstructured":"Knobloch, J., Shaughnessy, J. D., Jr & Ruther, U. Thalidomide induces limb deformities by perturbing the Bmp\/Dkk1\/Wnt signaling pathway. FASEB J 21, 1410\u20131421 (2007).","journal-title":"FASEB J"},{"key":"BFsrep00679_CR11","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1096\/fj.10-178814","volume":"25","author":"CJ Lee","year":"2011","unstructured":"Lee, C. J., Goncalves, L. L. & Wells, P. G. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism. FASEB J 25, 2468\u20132483 (2011).","journal-title":"FASEB J"},{"key":"BFsrep00679_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/152308604771978291","volume":"6","author":"JM Hansen","year":"2004","unstructured":"Hansen, J. M. & Harris, C. A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway. Antioxid Redox Signal 6, 1\u201314 (2004).","journal-title":"Antioxid Redox Signal"},{"key":"BFsrep00679_CR13","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1161\/01.CIR.0000014928.45119.73","volume":"105","author":"JP Cooke","year":"2002","unstructured":"Cooke, J. P. & Losordo, D. W. Nitric oxide and angiogenesis. Circulation 105(18), 2133\u20132135 (2002).","journal-title":"Circulation"},{"key":"BFsrep00679_CR14","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1242\/dev.01131","volume":"131","author":"AK Nath","year":"2004","unstructured":"Nath, A. K. et al. Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy. Development 131(10), 2485\u20132496 (2004).","journal-title":"Development"},{"key":"BFsrep00679_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cellimm.2011.03.018","volume":"270","author":"B Badamtseren","year":"2011","unstructured":"Badamtseren, B. et al. Thalidomide inhibits interferon-gamma-mediated nitric oxide production in mouse vascular endothelial cells. Cell Immunol 270, 19\u201324 (2011).","journal-title":"Cell Immunol"},{"key":"BFsrep00679_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2121-7-17","volume":"7","author":"KP Tamilarasan","year":"2006","unstructured":"Tamilarasan, K. P. et al. Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells. BMC Cell Biol 7, 17 (2006).","journal-title":"BMC Cell Biol"},{"key":"BFsrep00679_CR17","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1111\/j.1476-5381.2009.00446.x","volume":"158","author":"S Majumder","year":"2009","unstructured":"Majumder, S. et al. Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase. Br J Pharmacol 158, 1720\u20131734 (2009).","journal-title":"Br J Pharmacol"},{"key":"BFsrep00679_CR18","first-page":"640","volume":"12","author":"F Kemper","year":"1962","unstructured":"Kemper, F. Thalidomide and development of the chick embryo. Arzneimittelforschung 12, 640\u2013641 (1962a)","journal-title":"Arzneimittelforschung"},{"key":"BFsrep00679_CR19","first-page":"289","volume":"16","author":"A Jurand","year":"1966","unstructured":"Jurand, A. Early changes in limb buds of chick embryos after thalidomide treatment. J Embryol Exp Morphol 16(2), 289\u2013300 (1966).","journal-title":"J Embryol Exp Morphol"},{"key":"BFsrep00679_CR20","first-page":"2719","volume":"256","author":"B Salzgeber","year":"1963","unstructured":"Salzgeber, B. & Salaun, J. Malformations of extremities obtained in the chick embryo after treatment by thalidomide. C.r. hebd. Seanc. Acad. Sci. 256, 2719\u20132722 (1963).","journal-title":"C.r. hebd. Seanc. Acad. Sci."},{"key":"BFsrep00679_CR21","doi-asserted-by":"publisher","first-page":"e1228","DOI":"10.1371\/journal.pone.0001228","volume":"2","author":"W Weng","year":"2007","unstructured":"Weng, W., Sukowati, E. W. & Sheng, G. On hemangioblasts in chicken. PLoS One 2(11), e1228 (2007).","journal-title":"PLoS One"},{"key":"BFsrep00679_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/BF00186983","volume":"186","author":"R Seifert","year":"1992","unstructured":"Seifert, R., Zhao, B. & Christ, B. Cytokinetic studies on the aortic endothelium and limb bud vascularization in avian embryos. Anat Embryol (Berl) 186, 601\u2013610 (1992).","journal-title":"Anat Embryol (Berl)"},{"key":"BFsrep00679_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1874091X01105010037","volume":"5","author":"D Tweedie","year":"2011","unstructured":"Tweedie, D. Frankola, K. A., Luo, Y. Li. & Greig, N. H. Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-alpha and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation. Open Biochem J 5, 37\u201344 (2011).","journal-title":"Open Biochem J"},{"key":"BFsrep00679_CR24","doi-asserted-by":"publisher","first-page":"G167","DOI":"10.1152\/ajpgi.00385.2009","volume":"298","author":"P Rafiee","year":"2010","unstructured":"Rafiee, P., Stein, J. D., Nelson, V. M. et al. Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). Am J Physiol Gastrointest Liver Physiol 298, G167\u2013G176 (2010).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFsrep00679_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1574-695X.2009.00567.x","volume":"56","author":"AS Noman","year":"2009","unstructured":"Noman, A. S. et al. Thalidomide inhibits lipopolysaccharide-induced nitric oxide production and prevents lipopolysaccharide-mediated lethality in mice. FEMS Immunol Med Microbiol 56, 204\u2013211 (2009).","journal-title":"FEMS Immunol Med Microbiol"},{"key":"BFsrep00679_CR26","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1172\/JCI1560","volume":"101","author":"T Murohara","year":"1998","unstructured":"Murohara, T. et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101(11), 2567\u20132578 (1998).","journal-title":"J Clin Invest"},{"key":"BFsrep00679_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0014-2999(98)00511-1","volume":"356","author":"K Homer","year":"1998","unstructured":"Homer, K. & Wanstall, J. In vitro comparison of two NONOates (novel nitric oxide donors) on rat pulmonary arteries. Eur J Pharmacol 356, 49\u201357 (1998).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep00679_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/tera.1420520304","volume":"52","author":"LE Kotch","year":"1995","unstructured":"Kotch, L. E., Chen, S. Y. & Sulik, K. K. Ethanol-induced teratogenesis: free radical damage as a possible mechanism. Teratology 52, 128\u2013136 (1995).","journal-title":"Teratology"},{"key":"BFsrep00679_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.phrs.2009.02.011","volume":"60","author":"ME Crespo-Lopez","year":"2009","unstructured":"Crespo-Lopez, M. E. et al. Mercury and human genotoxicity: critical considerations and possible molecular mechanisms. Pharmacol Res 60, 212\u2013220 (2009).","journal-title":"Pharmacol Res"},{"key":"BFsrep00679_CR30","doi-asserted-by":"crossref","unstructured":"Kotla, V. et al. Mechanism of action of lenalidomide in hematological malignancies. J Hematol Oncol 2\u201336 (2009).","DOI":"10.1186\/1756-8722-2-36"},{"key":"BFsrep00679_CR31","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1016\/S0968-0896(02)00152-9","volume":"10","author":"LM Lima","year":"2002","unstructured":"Lima, L. M. et al. Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues. Bioorg Med Chem 10, 3067\u20133073 (2002).","journal-title":"Bioorg Med Chem"},{"key":"BFsrep00679_CR32","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito, T. et al. Identification of a primary target of thalidomide teratogenicity. Science 327(5971), 1345\u20131350 (2010).","journal-title":"Science"},{"key":"BFsrep00679_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1084\/jem.185.4.601","volume":"185","author":"S Dimmeler","year":"1997","unstructured":"Dimmeler, S., Haendeler, J., Nehls, M. & Zeiher, A. M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 185, 601\u2013608 (1997).","journal-title":"J Exp Med"},{"key":"BFsrep00679_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainres.2004.11.024","volume":"1034","author":"S Figueroa","year":"2005","unstructured":"Figueroa, S. et al. SNAP, a NO donor, induces cellular protection only when cortical neurons are submitted to some aggression process. Brain Res 1034(1\u20132), 25\u201333 (2005).","journal-title":"Brain Res"},{"key":"BFsrep00679_CR35","doi-asserted-by":"publisher","first-page":"31138","DOI":"10.1074\/jbc.272.49.31138","volume":"272","author":"YM Kim","year":"1997","unstructured":"Kim, Y. M., Talanian, R. V. & Billiar, T. R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272, 31138\u201331148 (1997).","journal-title":"J Biol Chem"},{"key":"BFsrep00679_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.1098219","volume":"305","author":"ME Giannakou","year":"2004","unstructured":"Giannakou, M. E. et al. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305(5682), 361 (2004).","journal-title":"Science"},{"key":"BFsrep00679_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jcp.20953","volume":"211","author":"B Venkatesan","year":"2007","unstructured":"Venkatesan, B. et al. Downregulation of catalase by reactive oxygen species via PI 3 kinase\/Akt signaling in mesangial cells. J Cell Physiol 211, 457\u2013467 (2007).","journal-title":"J Cell Physiol"},{"key":"BFsrep00679_CR38","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0006-291X(87)80299-1","volume":"148","author":"MW Radomski","year":"1987","unstructured":"Radomski, M. W., Palmer, R. M. & Moncada, S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148, 1482\u20131489 (1987).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep00679_CR39","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/cbdv.200800014","volume":"6","author":"T Wang","year":"2009","unstructured":"Wang, T. et al. Synthesis and biological evaluation of nitric oxide-donating thalidomide analogues as anticancer agents. Chem Biodivers 6, 466\u2013474 (2009).","journal-title":"Chem Biodivers"},{"key":"BFsrep00679_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/jmor.1050880104","volume":"88","author":"V Hamburger","year":"1951","unstructured":"Hamburger, V. & Hamilton, H. L. A series of normal stages in the development of the chick embryo. J Morphol 88, 49\u201392 (1951).","journal-title":"J Morphol"},{"key":"BFsrep00679_CR41","unstructured":"Weld, M. W. The Zebrafish Book. .A Guide for the Laboratory Use of Zebrafish (danio rerio), University of Oregon Press, Eugene, OR, (2000)."},{"key":"BFsrep00679_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/aja.1002030302","volume":"203","author":"CB Kimmel","year":"1995","unstructured":"Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. & Schilling, T. F. Stages of embryonic development of the zebrafish . Dev Dyn 203, 253\u2013310 (1995).","journal-title":"Dev Dyn"},{"key":"BFsrep00679_CR43","first-page":"65","volume":"41","author":"VR Muthukkaruppan","year":"2000","unstructured":"Muthukkaruppan, V. R., Shinners, B. L., Lewis, R., Park, S-J., Baechler, B. J. & Auerbach, R. The chick embryo aortic arch assay: a new, rapid, quantifiable in vitro method for testing the efficacy of angiogenic and anti-angiogenic factors in a three-dimensional, serum free organ culture system. Proc Am Assoc Cancer Res. 41, 65 (2000).","journal-title":"Proc Am Assoc Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep00679","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:23:05Z","timestamp":1672978985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep00679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,12,21]]}},"alternative-id":["BFsrep00679"],"URL":"https:\/\/doi.org\/10.1038\/srep00679","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,20]]},"assertion":[{"value":"18 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"679"}}